Policy | 27 July 2022
Pharmaceuticals industry under Atmanirbhar Bharat programme
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
India exported about Rs 33,321 crore and imported Rs 35,249 crore worth APIs and Bulk drugs in 2021-22.
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
The Bill aims to amend and consolidate the law relating to the import, manufacture, distribution and sale of drugs, medical devices and cosmetics
It includes both public and private health facilities including hospitals, clinics, diagnostic laboratories, and imaging centers
Govt committed to supporting pharma companies with industry-friendly policies
National Institute of Biologicals should undertake the testing of more biologicals and also extend its testing expertise in helping other countries
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
The Minister lauded and extended his gratitude to the scientists who developed the vaccine during pandemic.
The Minister directed officials to continue to focus on surveillance and on Whole Genome Sequencing to scan for any possible mutation and also directed for monitoring hospitalizations due to COVID-19 and SARI/ILI cases
The Ayushman Bharat Digital Mission (ABDM) aims to replicate this success in healthcare delivery by building an equitable, accessible and inclusive ecosystem
Increased and timely testing will enable early identification of COVID cases and help to curb spread of the infection among the community
States have an important role in ensuring food safety and healthy food practices.
This MoU will further strengthen relations between India and the USA within the framework of international scientific and technological cooperation in fields of mutual interest.
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
Govt. has set a target to increase the number of JanAushadhi Kendras to 10,000 by March 2024
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Subscribe To Our Newsletter & Stay Updated
